Spots Global Cancer Trial Database for Assessment of Early-detection Based on Liquid Biopsy in Lymphoid Malignancies
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Assessment of Early-detection Based on Liquid Biopsy in Lymphoid Malignancies
Official Title: Assessment of Early-detection Based on Liquid Biopsy in Lymphoid Malignancies: a Multi-center Prospective Observational Study
Study ID: NCT05275036
Conditions
Interventions
Study Description
Brief Summary: ASCEND-LYM is a prospective, multi-center, observational study aimed at detecting early stage lymphoma and constrcuting prognostic model by combined assays of cfDNA methylation and other biomarkers. The study will enroll approximately 493 participants including lymphoid malignancies and benign diseases.
Detailed Description:
Eligibility
Minimum Age: 40 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
SunYat-sen university cancer center, Guangzhou, , China
Contact Details
Name: Huiqiang Huang, Ph.D
Affiliation: Department of Medical Oncology, Sun Yat-sen University Cancer Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
